ישראל - עברית - Ministry of Health

medison pharma ltd - fampridine - טבליות בשחרור ממושך - fampridine 10 mg - fampridine - fampridine - fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7)

ישראל - עברית - Ministry of Health

medison pharma ltd - peginterferon beta 1a - תמיסה להזרקה - peginterferon beta 1a 125 mcg / 0.5 ml - peginterferon beta-1a

ישראל - עברית - Ministry of Health

medison pharma ltd - peginterferon beta 1a - תמיסה להזרקה - peginterferon beta 1a 63 mcg / 0.5 ml - peginterferon beta-1a

ישראל - עברית - Ministry of Health

medison pharma ltd - peginterferon beta 1a - תמיסה להזרקה - peginterferon beta 1a 94 mcg / 0.5 ml - peginterferon beta-1a

ישראל - עברית - Ministry of Health

medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.

ישראל - עברית - Ministry of Health

medison pharma ltd - nusinersen - תמיסה להזרקה - nusinersen 2.4 mg / 1 ml

ישראל - עברית - Ministry of Health

medison pharma ltd - nusinersen - תמיסה להזרקה - nusinersen 2.4 mg / 1 ml

ישראל - עברית - Ministry of Health

medison pharma ltd - nusinersen - תמיסה להזרקה - nusinersen 2.4 mg / 1 ml

ישראל - עברית - Ministry of Health

medison pharma ltd - nusinersen - תמיסה להזרקה - nusinersen 2.4 mg / 1 ml

ישראל - עברית - Ministry of Health

medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.